Numerous studies have proven that a high level of plasma adropin reduces insulin resistance and glucose intolerance and that adropin can stimulate glucose consumption and improve carbohydrate and energy metabolism (Kumar et al., 2008; Ganesh Kumar et al., 2012; Gao et al., 2014; Akcilar et al., 2016b). The gene discussed is ENHO; the disease is Insulin resistance.